| Product Code: ETC10600609 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human insulin drugs and delivery devices to the Philippines in 2024 reveal a diverse mix of exporting countries, with Switzerland, India, South Korea, Germany, and the USA leading the way. Despite the negative growth trends indicated by a CAGR of -17.36% from 2020 to 2024 and a significant decline in growth rate of -47.02% from 2023 to 2024, the market remains characterized by low concentration levels, as reflected by the HHI. This suggests that the market for human insulin products in the Philippines continues to attract a variety of international suppliers, ensuring competitive pricing and availability for consumers.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Human Insulin Drugs and Delivery Devices Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Human Insulin Drugs and Delivery Devices Market - Industry Life Cycle |
3.4 Philippines Human Insulin Drugs and Delivery Devices Market - Porter's Five Forces |
3.5 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Insulin Type, 2021 & 2031F |
3.6 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Delivery Device, 2021 & 2031F |
3.7 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Patient Demographic, 2021 & 2031F |
3.9 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Treatment Goal, 2021 & 2031F |
4 Philippines Human Insulin Drugs and Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Human Insulin Drugs and Delivery Devices Market Trends |
6 Philippines Human Insulin Drugs and Delivery Devices Market, By Types |
6.1 Philippines Human Insulin Drugs and Delivery Devices Market, By Insulin Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Type, 2021 - 2031F |
6.1.3 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Rapid-Acting Insulin, 2021 - 2031F |
6.1.4 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-Acting Insulin, 2021 - 2031F |
6.1.5 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Pre-mixed Insulin, 2021 - 2031F |
6.1.6 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Glargine, 2021 - 2031F |
6.2 Philippines Human Insulin Drugs and Delivery Devices Market, By Delivery Device |
6.2.1 Overview and Analysis |
6.2.2 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pens, 2021 - 2031F |
6.2.3 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps, 2021 - 2031F |
6.2.4 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Syringes, 2021 - 2031F |
6.2.5 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps/Pens, 2021 - 2031F |
6.3 Philippines Human Insulin Drugs and Delivery Devices Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.5 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Philippines Human Insulin Drugs and Delivery Devices Market, By Patient Demographic |
6.4.1 Overview and Analysis |
6.4.2 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.4.3 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.4.4 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Children, Adults, 2021 - 2031F |
6.4.5 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Elderly Population, 2021 - 2031F |
6.5 Philippines Human Insulin Drugs and Delivery Devices Market, By Treatment Goal |
6.5.1 Overview and Analysis |
6.5.2 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Blood Sugar Control, 2021 - 2031F |
6.5.3 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-term Glycemic Control, 2021 - 2031F |
6.5.4 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Immediate Blood Sugar Regulation, 2021 - 2031F |
6.5.5 Philippines Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Overnight Glucose Control, 2021 - 2031F |
7 Philippines Human Insulin Drugs and Delivery Devices Market Import-Export Trade Statistics |
7.1 Philippines Human Insulin Drugs and Delivery Devices Market Export to Major Countries |
7.2 Philippines Human Insulin Drugs and Delivery Devices Market Imports from Major Countries |
8 Philippines Human Insulin Drugs and Delivery Devices Market Key Performance Indicators |
9 Philippines Human Insulin Drugs and Delivery Devices Market - Opportunity Assessment |
9.1 Philippines Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Insulin Type, 2021 & 2031F |
9.2 Philippines Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Delivery Device, 2021 & 2031F |
9.3 Philippines Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Philippines Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Patient Demographic, 2021 & 2031F |
9.5 Philippines Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Treatment Goal, 2021 & 2031F |
10 Philippines Human Insulin Drugs and Delivery Devices Market - Competitive Landscape |
10.1 Philippines Human Insulin Drugs and Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Philippines Human Insulin Drugs and Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |